Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
This summary needs review. Please check the official study record and contact the research team for details.
In United States
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It is testing modafinil for ADHD.
In United StatesThis study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
In United StatesThis study is completed in the United States. It is testing vyvanse (Lisdexamfetamine Dimesylate) for ADHD.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States, in India, in Russia, .... It is testing Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo for schizophrenia.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study was terminated in the United States. It focuses on Schizophrenia.
In United StatesThis study is completed in the United States. It focuses on OCD.
In United StatesThis study is completed in the United States. It is testing Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD.
Remote / onlineHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.